Free Trial

Synlogic (SYBX) Competitors

Synlogic logo
$1.72 -0.06 (-3.37%)
Closing price 10/22/2025 03:55 PM Eastern
Extended Trading
$1.74 +0.02 (+0.87%)
As of 10/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SYBX vs. IZTC, IMMX, XBIT, VXRT, RPTX, LITS, CRVO, EQ, HOWL, and COEP

Should you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include Invizyne Technologies (IZTC), Immix Biopharma (IMMX), XBiotech (XBIT), Vaxart (VXRT), Repare Therapeutics (RPTX), Lite Strategy (LITS), CervoMed (CRVO), Equillium (EQ), Werewolf Therapeutics (HOWL), and Coeptis Therapeutics (COEP). These companies are all part of the "pharmaceutical products" industry.

Synlogic vs. Its Competitors

Synlogic (NASDAQ:SYBX) and Invizyne Technologies (NASDAQ:IZTC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synlogic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Invizyne Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Synlogic's average media sentiment score of 0.00 equaled Invizyne Technologies'average media sentiment score.

Company Overall Sentiment
Synlogic Neutral
Invizyne Technologies Neutral

Invizyne Technologies' return on equity of 0.00% beat Synlogic's return on equity.

Company Net Margins Return on Equity Return on Assets
SynlogicN/A -8.09% -5.50%
Invizyne Technologies N/A N/A N/A

63.4% of Synlogic shares are held by institutional investors. 3.0% of Synlogic shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Invizyne Technologies has lower revenue, but higher earnings than Synlogic.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Synlogic$10K2,012.40-$23.36M-$0.08-21.50
Invizyne TechnologiesN/AN/AN/AN/AN/A

Summary

Synlogic beats Invizyne Technologies on 4 of the 6 factors compared between the two stocks.

Get Synlogic News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYBX vs. The Competition

MetricSynlogicMED IndustryMedical SectorNASDAQ Exchange
Market Cap$20.82M$3.47B$6.16B$10.67B
Dividend YieldN/A2.24%5.72%4.86%
P/E Ratio-21.5022.9129.0927.13
Price / Sales2,012.40463.56571.59126.20
Price / CashN/A45.5937.1261.42
Price / Book1.5810.2912.206.43
Net Income-$23.36M-$52.53M$3.33B$276.63M
7 Day Performance1.18%-0.60%-0.78%-0.77%
1 Month Performance-0.86%10.30%5.28%0.68%
1 Year Performance23.74%13.51%68.39%32.03%

Synlogic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYBX
Synlogic
N/A$1.72
-3.4%
N/A+20.3%$20.82M$10K-21.5080
IZTC
Invizyne Technologies
N/A$12.95
-4.1%
N/AN/A$80.96MN/A0.0029
IMMX
Immix Biopharma
2.6921 of 5 stars
$2.42
-3.4%
$8.00
+231.3%
+87.3%$79.96MN/A-3.149
XBIT
XBiotech
1.7882 of 5 stars
$2.53
-1.3%
N/A-66.8%$77.72M$4.01M-2.77100News Coverage
Short Interest ↓
VXRT
Vaxart
1.7533 of 5 stars
$0.34
-0.1%
$2.00
+490.0%
-55.6%$77.61M$47.40M-1.26120Gap Down
RPTX
Repare Therapeutics
2.7515 of 5 stars
$1.81
-0.3%
$4.50
+148.1%
-45.7%$77.54M$53.48M-0.70180
LITS
Lite Strategy
N/A$2.14
-0.5%
N/AN/A$76.29M$65.30M-0.45100
CRVO
CervoMed
3.4338 of 5 stars
$8.16
+1.9%
$19.29
+136.3%
-40.6%$75.34M$9.74M-3.124
EQ
Equillium
0.6902 of 5 stars
$1.27
-1.2%
$1.00
-20.9%
+20.6%$75.27M$41.10M-2.2640News Coverage
Short Interest ↑
HOWL
Werewolf Therapeutics
3.8726 of 5 stars
$1.67
+2.5%
$8.00
+379.0%
-56.2%$75.23M$1.88M-1.0040
COEP
Coeptis Therapeutics
0.7916 of 5 stars
$15.59
+0.3%
N/A+227.4%$75.14MN/A-2.692Short Interest ↑

Related Companies and Tools


This page (NASDAQ:SYBX) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners